Vita Life Sciences Limited · ASX:VLS
Vita Life Sciences — Shareholder Meeting (May 2022)
40 slides from Vita Life Sciences's shareholder meeting presentation, May 11, 2022
Slide 1: Annual General Meeting - Address & Presentation (ASX cover letter)
For personal use only 11 May 2022 Company Announcements Office Australian Securities Exchange 20 Bridge Street Sydney NSW 2000 Dear Sir/ Madam, ANNUAL GENERAL MEETING-ADDRESS & PRESENTATION The Vita Life Sciences Ltd addresses to the 2022 AGM by the Chairman and the Managing Director with related pr
Slide 2: Chairman's Script
For personal use only Vita Life Sciences Limited – 2022 Annual General Meeting Chairman’s Script
Slide 3: Chairman's Script - Welcome and Introduction
Vita Life Sciences Limited – 2022 Annual General Meeting Chairman’s Script - 11 May 2022 Welcome For personal use only Good afternoon ladies and gentlemen. I am Greg Ralph, a Director of Vita Life Sciences Limited and the Chairman for the Annual General Meeting today. Welcome to the VLS 2022 Annual
Slide 4: Chairman's Script - Questions and Managing Director handover
As this meeting is being conducted as a hybrid meeting, I would like to welcome those shareholders that are joining us online and ask that you please submit any questions or comments via the Q&A function which can be found at the bottom of your screen. When you For personal use only submit a questio
Slide 5: Chairman's Script - Voting instructions
Shareholders in attendance online who have already submitted their votes by proxy should note that your votes will already be counted towards the poll. You do not need to lodge another vote unless you wish to change your votes. For personal use only Shareholders in attendance online who have not sub
Slide 6: Financial Reports and Remuneration Report
the conduct of the audit and the preparation and content of the independent auditor’s report. If you have any questions or wish to discuss this resolution, please submit your questions For personal use only via the Q&A. Is there any discussion or questions on the 2021 Financial Reports? Are there an
Slide 7: Resolution 2: Re-election of Shane Teoh
Members of the Company’s key management personnel who were named in the FY2021 remuneration report and their closely related parties are reminded that they may not vote on this resolution. For personal use only Shareholders may now vote on Resolution 1. May I again remind shareholders not to click o
Slide 8: Resolution 3 and 4: Re-election and Share Buy-Back
I put forward Resolution 3: To consider and, if thought fit, to pass, with or without amendment, Resolution 3, as an ordinary resolution. For personal use only “That Henry Townsing, a director retiring by rotation in accordance with rule 5.1 of the Constitution, being eligible and having consented t
Slide 9: Resolution 4 and 5: Share Buy-Back and Incentive Plan
shares in the Company expiring on whichever is the earlier of the anniversary of the passage of this resolution or the 2023 Annual General Meeting and otherwise on the terms and conditions set out in the Explanatory Statement accompanying the 2022 Annual General For personal use only Notice of Meeti
Slide 10: Resolution 5 and 6: Long Term Incentive Plan
will be used to fund the purchase of shares, on the terms summarised in the Explanatory Statement accompanying the Notice of 2022 Annual General Meeting" An explanation of Resolution 5 is to be found from page 13 of the Explanatory Statement in For personal use only the Notice of AGM. The number of
Slide 11: Resolution 6 and close of formal business
be used to fund the purchase of shares, on the terms summarised in the Explanatory Statement accompanying the Notice of 2022 Annual General Meeting" An explanation of Resolution 6 is to be found from page 16 of the Explanatory Statement in For personal use only the Notice of AGM. The number of valid
Slide 12: Poll closing, other business and meeting close
I will now pause for about one minute to allow shareholders time to finalise and, submit their votes online. For personal use only Pause for a minute There being no further questions I now declare voting is closed. The staff of Automic will now process the poll and the results will be announced to t
Slide 13: Managing Director's Script
For personal use only Vita Life Sciences Limited – 2022 Annual General Meeting Managing Director’s Script
Slide 14: Address by the Managing Director
Vita Life Sciences Limited – 2022 Annual General Meeting Address by the Managing Director – 11 May 2022 Opening remarks For personal use only Thank you, Greg. Good afternoon and a warm welcome to all shareholders, VLS Board of directors and to the Vita Life Sciences Executive Team. My name is Andrew
Slide 15: Consumer demand and strong financial performance
The consumer demand for immunity products continued throughout FY21. The consumers were researching and seeking trusted products with high strength formulations to help support their health needs. Whilst, the immunity category drove the consumer demand, sub segments also experienced strong growth ac
Slide 16: Strategic pillars and key initiatives
• Talent Wellbeing: recruitment of additional management personal to support growth expectations • Operational leverage: ERP integration to increase supply chain and customer interface efficiencies. For personal use only The business has progressed well against our strategic pillars over the past 12
Slide 17: Presentation Materials
For personal use only Vita Life Sciences Limited – 2022 Annual General Meeting Presentation Materials
Slide 18: AGM Registration and Voting
Vita Life Sciences AGM - Registration and Voting For personal use only 1. Log in or register at: 2. Click view and register 3. Record your vote. Once https://investor.automic.com.au/#/home your attendance for the you confirm it is lodged and meeting final To contact support: Call 1300 816 159 or ope
Slide 19: Annual General Meeting
For personal use only Annual General Meeting 11 May 2022
Slide 20: AGM Agenda
AGM Agenda For personal use only 1. CHAIRMAN’S WELCOME ADDRESS 2. MANAGING DIRECTOR’S REVIEW 3. ORDINARY RESOLUTIONS 4. QUESTIONS & ANSWERS ANNUAL GENERAL MEETING 2022
Slide 21: Henry Townsing, Chairman
For personal use only Henry Townsing Chairman Mr Townsing brings over 30 years’ experience in corporate finance and private equity. He was a Director of the Company, from 1985 to 1992, 2004 to 2009 and was reappointed a Director on 22nd December 2011. Mr Townsing was appointed as the Chairman of the
Slide 22: AGM Agenda
AGM Agenda For personal use only 1. CHAIRMAN’S WELCOME ADDRESS 2. MANAGING DIRECTOR’S REVIEW 3. ORDINARY RESOLUTIONS 4. QUESTIONS & ANSWERS ANNUAL GENERAL MEETING 2022
Slide 23: Andrew O'Keefe, Managing Director
For personal use only Andrew O’Keefe Managing Director Mr O’Keefe was appointed Managing Director on 1st January 2017. Mr O’Keefe has over 20 years’ experience within the Australian pharmaceutical and healthcare industry. During his career Mr O’Keefe has held senior leadership positions in publicly
Slide 24: Thank you
For personal use only Thank you ANNUAL GENERAL MEETING 2022
Slide 25: Meeting Consumer Demand
For personal use only Meeting Consumer Demand Distribution - Across several markets; Australia, Malaysia, Singapore, China, Vietnam, Thailand, and Indonesia Brands – Herbs of Gold, VitaHealth & VitaScience brands Products – 750 registered products across all markets Strong consumer demand – The Grou
Slide 26: Strong Financial Performance
For personal use only Strong Financial Performance Record Sales Pre-Tax Profit Balance sheet equity Dividend payment $57.1m, up 23% $11.2m, up 38% $30.4m, net cash $15.9m 5.75 cents/share, (without any borrowings) up 35% ANNUAL GENERAL MEETING 2022
Slide 27: Geographical Performance
For personal use only Geographical Performance Australia is the single largest market with an increase of 45% to 53% in market share. 2021 revenue by geography Other Asia 4% $2M Australia 53% Singapore 10% $5.6M $30.3M Asia Total 47% revenue $57.1m Malaysia 34% $19.2M ANNUAL GENERAL MEETING 2022
Slide 28: Strategic Priorities
For personal use only Strategic priorities Our pillars BRAND BUILDING EDUCATION & INNOVATION TALENT WELLBEING OPERATIONAL LEVERAGE Key initiatives to support our pillars OVER 1000 RECRUITMENT OF NEW BUSINESS MODEL NEW ERP SYSTEM INCREASED BRANDING PHARMACIES RANGING NATIONAL TRAINING 30 NEW PRODUCTS
Slide 29: Outlook
For personal use only Outlook • The Group continues to be very well positioned to leverage market opportunities across the region. • The plans and vision for the business are strong and robust to drive future growth. • First half guidance will be provided early June. ANNUAL GENERAL MEETING 2022
Slide 30: AGM Agenda
AGM Agenda For personal use only 1. CHAIRMAN’S WELCOME ADDRESS 2. MANAGING DIRECTOR’S REVIEW 3. ORDINARY RESOLUTIONS 4. QUESTIONS & ANSWERS ANNUAL GENERAL MEETING 2022
Slide 31: Ordinary Resolutions
Ordinary Resolutions For personal use only 1. Remuneration Report 2. Re-election of Director – Shane Teoh 3. Re-election of Director- Henry Townsing 4. Share buy back 5. Long Term Incentive Plan Shares-Managing Director 6. Long Term Incentive Plan Shares-Director ANNUAL GENERAL MEETING 2022
Slide 32: Proxy - Resolution 1
Proxy-Resolution 1 For personal use only PROXY’S RESOLUTIONS IN FAVOUR AGAINST EXCLUDED DISCRETION 1) Adoption of the Remuneration Report 25,502,045 43,100 0 11,220,054 ANNUAL GENERAL MEETING 2022
Slide 33: Proxy - Resolution 2
Proxy-Resolution 2 For personal use only PROXY’S RESOLUTIONS IN FAVOUR AGAINST EXCLUDED DISCRETION Re-election of Director 2) (Shane Teoh) 38,153,410 21,915 0 0 ANNUAL GENERAL MEETING 2022
Slide 34: Proxy - Resolution 3
Proxy-Resolution 3 For personal use only PROXY’S RESOLUTIONS IN FAVOUR AGAINST EXCLUDED DISCRETION Re-election of Director 3) (Henry Townsing) 37,429,676 66,915 0 0 ANNUAL GENERAL MEETING 2022
Slide 35: Proxy - Resolution 4
Proxy-Resolution 4 For personal use only PROXY’S RESOLUTIONS IN FAVOUR AGAINST EXCLUDED DISCRETION 4) Share buy-back 38,127,790 50,344 0 0 ANNUAL GENERAL MEETING 2022
Slide 36: Proxy - Resolution 5
Proxy-Resolution 5 For personal use only PROXY’S RESOLUTIONS IN FAVOUR AGAINST EXCLUDED DISCRETION Long Term Investment Plan Shares- 5) Managing Director 25,426,542 164,047 0 11,077,054 ANNUAL GENERAL MEETING 2022
Slide 37: Proxy - Resolution 6
Proxy-Resolution 6 For personal use only PROXY’S RESOLUTIONS IN FAVOUR AGAINST EXCLUDED DISCRETION Long Term Investment Plan Shares- 6) Director 25,350,385 240,204 0 10,394,446 ANNUAL GENERAL MEETING 2022
Slide 38: Proxy - All Resolutions
Proxy For personal use only PROXY’S RESOLUTIONS IN FAVOUR AGAINST EXCLUDED DISCRETION 1) Adoption of the Remuneration Report 25,502,045 43,100 0 11,220,054 Re-election of Director 2) 38,153,410 21,915 0 0 (Shane Teoh) Re-election of Director 3) (Henry Townsing) 37,429,676 66,915 0 0 4) Share buy-bac
Slide 39: AGM Agenda
AGM Agenda For personal use only 1. CHAIRMAN’S WELCOME ADDRESS 2. MANAGING DIRECTOR’S REVIEW 3. ORDINARY RESOLUTIONS 4. QUESTIONS & ANSWERS ANNUAL GENERAL MEETING 2022
Slide 40: Disclaimer
For personal use only Disclaimer ANNUAL GENERAL MEETING 2022